- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02596282
Enhanced Provision of Male Circumcision (MC) for HIV Prevention, Rakai, Uganda
A Randomized Trial of the Acceptability and Safety of Early Infant Male Circumcision (EIMC) Conducted by Nurse Midwives and Clinical Offices Using the Mogen Clamp
Background: Medical male circumcision (MMC) for HIV prevention is a priority in 14 East and Southern African countries, and the long-term sustainability of MMC programs could best be achieved by early infant male circumcision (EIMC.) However, the acceptability and safety of EIMC provided by non-physicians is unknown.
Methods: We conducted a trial of EIMC using the Mogen clamp provided by newly trained clinical officers (CO) and nurse midwives (NMWs) in 4 health centers in rural Rakai, Uganda. 501 healthy neonates aged 1-28 days with normal birth weight and gestational age were randomized to CO (n=256) and NMWs (n=245), and were followed up at 24 hours, 7 and 28 days. Combined analgesia was provided by paracetamol suppository, Eutectic Mixture of Local Anesthetics (EMLA) cream and a 24% sucrose solution.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The objective was to assess the acceptability and safety of neonatal male circumcision performed by clinical officers (equivalent to US physician assistants) and nurse midwives, using the Mogen clamp.
This was a randomized, blinded trial of circumcision using the Mogen clamp under topical anesthesia in healthy male infants aged 1-28 days, with normal birth weight and gestational age, performed by trained clinical officers or nurse midwives, randomized 1:1 in Rakai District, Uganda.
Mothers of male infants born in 4 health centers were invited to participate and signed an informed consent for screening and enrollment. Infants were screened on enrollment prior to randomization (1;1) to clinical officer and nurse midwife circumcision providers.
Follow up was via a phone call at 24 hours, 7 days and 4 weeks post-circumcision.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age 1-28 days
- birth weight >= 2,500 gm
- gestational age >=37 weeks
- no illness. normal temperature
- no genital anatomic abnormality
Exclusion Criteria:
- age >28 days
- birth weight <2,500 gm
- gestational age <37 weeks
- Ill health
- genital abnormality
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Clinical Officer (CO),
COs were trained and provided neonatal male circumcision under topical anesthesia using the Mogen clamp
|
The standard procedure for neonatal circumcision is as follows: combined analgesia was topical 2.5% lidocaine and 2.5% prilocaine <1 gm applied 60 minutes and 40mg acetaminophen suppository 30 minutes prior to surgery. Infants were given a 24% sucrose solution pacifier if needed. Infants under 2 weeks of age received subcutaneous Vitamin K 1 mg. The perineum cleaned, and the penis swabbed with povidone iodine. Hemostats were applied at 3 and 9 o'clock positions and the glans pushed down. Traction was applied before placing the Mogen clamp, the clamp was closed for 5 minutes and the foreskin removed with a scalpel. Petroleum jelly (e.g., Vaseline) was applied to the glans and the wound covered with sterile gauze. Infants were observed for one hour. Mothers were instructed in wound care.
Other Names:
|
Experimental: Nurse Midwife (NMW)
NMWs were trained and provided neonatal male circumcision under topical anesthesia using the Mogen clamp
|
The standard procedure for neonatal circumcision is as follows: combined analgesia was topical 2.5% lidocaine and 2.5% prilocaine <1 gm applied 60 minutes and 40mg acetaminophen suppository 30 minutes prior to surgery. Infants were given a 24% sucrose solution pacifier if needed. Infants under 2 weeks of age received subcutaneous Vitamin K 1 mg. The perineum cleaned, and the penis swabbed with povidone iodine. Hemostats were applied at 3 and 9 o'clock positions and the glans pushed down. Traction was applied before placing the Mogen clamp, the clamp was closed for 5 minutes and the foreskin removed with a scalpel. Petroleum jelly (e.g., Vaseline) was applied to the glans and the wound covered with sterile gauze. Infants were observed for one hour. Mothers were instructed in wound care.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adverse events related to circumcision
Time Frame: 4 weeks
|
Adverse events graded as mild, moderate and severe
|
4 weeks
|
Acceptability as measured by the proportion of mothers directly informed about the study who consented to enroll in the trial
Time Frame: through study completion, an of 1 year
|
Proportion of registered mother-child pairs in which the male infant was circumcised
|
through study completion, an of 1 year
|
Wound healing
Time Frame: 4 weeks
|
Completed wound healing (clean intact scar without a scab or stitch sinus)
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Procedure time
Time Frame: Less than 15 minutes
|
Length of time from preoperative prep to completion
|
Less than 15 minutes
|
Parental satisfaction
Time Frame: 4 weeks
|
Mother's report of satisfaction with the procedure
|
4 weeks
|
Neonatal pain scale (NIPS)
Time Frame: During surgery
|
based of facial expression, crying, breathing patterns, movement of arms and legs, and state of arousal.
NIPS scores 0 were classified as no pain, scores 1-2 mild, scores 3-4 as moderate and >4 as severe pain.
|
During surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ronald H Gray, MD MSc, Johns Hopkins Bloomberg School of Public Health
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00004524
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neonatal Male Circumcision
-
University of Alabama at BirminghamUniversity Teaching Hospital, Lusaka, ZambiaCompletedNeonatal Male CircumcisionZambia
-
ProgressusUnknownCircumcision, Male | Circumcision Status: Circumcised, Uncircumcised
-
University of North Carolina, Chapel HillBill and Melinda Gates Foundation; FHI 360; Impact Research & Development OrganizationCompletedVoluntary Medical Male Circumcision | Circumcision AdultKenya
-
Weill Medical College of Cornell UniversityBill and Melinda Gates FoundationCompleted
-
King Saud UniversityUnknownCircumcision, MaleSaudi Arabia
-
Medical University of South CarolinaCompleted
-
Simunye Primary Health CareCompleted
-
Kocatepe UniversityCompleted
-
FHI 360Weill Medical College of Cornell University; Bill and Melinda Gates Foundation and other collaboratorsCompletedMale CircumcisionKenya, Zambia
Clinical Trials on Neonatal circumcision under topical anesthesia
-
University of Alabama at BirminghamUniversity Teaching Hospital, Lusaka, ZambiaCompletedNeonatal Male CircumcisionZambia
-
Wenzhou Medical UniversityUnknownCorneal Opacity | Corneal Dystrophies, Hereditary | Keratitis, Herpetic | Corneal UlcerChina
-
Erasmus Medical CenterUniversitaire Ziekenhuizen KU Leuven; University of California, San Francisco; Medical Center HaaglandenRecruitingGlioblastomaUnited States, Belgium, Germany, Netherlands, Switzerland
-
Wenzhou Medical UniversityCompleted
-
Erasmus Medical CenterMassachusetts General Hospital; Universitaire Ziekenhuizen KU Leuven; University... and other collaboratorsRecruitingGlioblastoma | Brain Neoplasms | Recurrent Glioblastoma | Recurrent Adult Brain Tumor | Glioblastoma, IDH-wildtype | Glioblastoma Multiforme of Brain | Brain Neoplasms, Adult, Malignant | Astrocytoma, Malignant | Brain Neoplasms, AdultUnited States, Germany, Switzerland, Belgium, Netherlands
-
Hospital de ViladecansFundacio per la recerca e investigació del Hospital de ViladecansCompleted
-
Huashan HospitalCompletedBrain Neoplasms | Surgery | HyperemiaChina
-
Sun Yat-sen UniversityUnknownDifficult AirwayChina
-
Hannover Medical SchoolCompletedEqually of Delivery Systems of Local Anesthesia in BronchoscopyGermany
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalCompletedPregnancy Related | Regional Anesthesia Morbidity | Postdural Puncture HeadacheTurkey